全球甘氨酰环素市场 – 行业趋势及 2029 年预测

市场分析和规模

近年来，预计甘氨酰环素市场将在预测期内快速增长。根据联合国《2020 年世界人口老龄化重点研究》，预计全球老年人口将从 2020 年的 7.27 亿增加到 2050 年的 15 亿，增长近两倍，而 2020 年老年人口的比例约为 9.3%，预计到 2050 年将上升到 16%。由于人口老龄化，预计传染病负担将增加，从而补充预测期内市场的扩张。所有这些因素导致医疗保健领域对甘氨酰环素的需求很高。

Data Bridge Market Research 分析称，2021 年甘氨酰环素市场价值为 2.035 亿美元，预计到 2029 年将达到 2.5779 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 3.00%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

市场定义

甘氨酰环素是由四环素生成的，是一类新型抗生素。它们的诞生是为了解决细菌对四环素产生耐药性的问题。破坏细菌蛋白质合成的抗生素可阻止细菌繁殖。它们对革兰氏阴性菌和革兰氏阳性菌均具有广谱活性，但对四环素耐药菌特别有效。含有甘氨酰环素的抗生素对耐甲氧西林葡萄球菌、耐青霉素肺炎链球菌和耐万古霉素肠球菌有效。

报告范围和市场细分

Glycylcyclines Market Dynamics

Drivers

• Increasing prevalence of infectious diseases

The rising prevalence of infectious diseases is anticipated to influence the glycylcyclines market's growth. Intraabdominal infection, skin and structure infection, pneumonia, skin or soft tissue infection are the various medical ailments which are treated with the use of glycylcyclines.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of glycylcyclines market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the glycylcyclines market. Additionally, high disposable income and changing lifestyle of people will result in the expansion of glycylcyclines market. Sedentary lifestyle of people and rising pollution are the root causes behind the prevalence of various infectious diseases. Along with this, rising geriatric population and favourable reimbursement policies will enhance the growth rate of the market.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the glycylcyclines market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the glycylcyclines market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the drug development and distribution will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the glycylcyclines market. Additionally, side effects of glycylcyclines such as headache, photosensitivity, nausea, kidney diseases, tinnitus and hypersensitivity reactions will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This glycylcyclines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycylcyclines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Glycylcyclines market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Glycylcyclines Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations therefore as consequence of multiple precautionary lockdowns and other limitations imposed by governments all over the world. The glycylcyclines market is no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors are likely to have a negative impact on the glycylcyclines market's revenue trajectory.

Global Glycylcyclines Market Scope

The glycylcyclines? market is segmented on the basis of drug, application, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug

• Tygacil
• Other

On the basis of drug, the global hepatic drugs market is segmented into tygacil, and other.

Application

• Intraabdominal Infection
• Skin and Structure Infection
• Pneumonia
• Skin or Soft Tissue Infection
• Others

On the basis of application, the global hepatic drugs market is segmented into intraabdominal infection, skin and structure infection, pneumonia, skin or soft tissue infection and others.

Dosage

• Injection
• Powder
• Others

On the basis of dosage, the glycylcyclines market is segmented into injection, powder and others.  

Route of Administration

• Intravenous
• Others

The route of administration segment for the glycylcyclines market is segmented into intravenous and others.

 End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

On the basis of end-users, the glycylcyclines market is segmented into hospitals, specialty clinics, homecare and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

On the basis of distribution channel, the glycylcyclines market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Glycylcyclines Market Regional Analysis/Insights

The Glycylcyclines? market is analysed and market size insights and trends are provided by country, drug, application, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Glycylcyclines market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the glycylcyclines market because of the growing incidences of pneumonia in this region. Additionally, growing presence of major key players will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to rising healthcare expenditure and improvements in healthcare infrastructure in this region.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和甘氨酰环素 市场份额分析

甘氨酰环素市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对甘氨酰环素市场的关注有关。

甘氨酰环素市场的一些主要参与者包括：

• Accord Healthcare（美国）
• Amneal Pharmaceuticals LLC.（美国）
• Apotex Inc.（加拿大）
• 费森尤斯卡比公司（德国）
• 辉瑞公司（美国）
• 葛兰素史克公司 (英国)
• Meitheal Pharmaceuticals（美国）
• AuroMedics Pharma LLC（美国）
• Xellia Pharmaceuticals（美国）
• 阿斯利康（英国）
• 强生私人有限公司（美国）
• 安进公司 (美国)
• 诺华公司（瑞士）
• 雅培（美国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• 赛诺菲（法国）
• 默克公司（美国）
• AbbVie Inc.（美国）
• 太阳制药工业有限公司 (印度)
• 礼来公司 (美国)    

SKU-68171